MAPK14 and Werner syndrome: There is no known treatment for Werner syndrome, but several therapeutic options are being studied, mTOR inhibitors, selective inhibitors of p38 mitogen-activated protein kinase (MAPK), human induced pluripotent cells (hiPSCs) derived from fibroblasts from Werner syndrome patients, human embryonic stem cell (hESC) therapy (84–89).